258 related articles for article (PubMed ID: 30315146)
1. A Distinct Advantage to Intraarterial Delivery of
Lesniak WG; Chu C; Jablonska A; Du Y; Pomper MG; Walczak P; Janowski M
J Nucl Med; 2019 May; 60(5):617-622. PubMed ID: 30315146
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration.
Lesniak WG; Chu C; Jablonska A; Behnam Azad B; Zwaenepoel O; Zawadzki M; Lisok A; Pomper MG; Walczak P; Gettemans J; Janowski M
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1940-1951. PubMed ID: 31161257
[TBL] [Abstract][Full Text] [Related]
3. Molecular Drug Imaging:
Jansen MH; Veldhuijzen van Zanten SEM; van Vuurden DG; Huisman MC; Vugts DJ; Hoekstra OS; van Dongen GA; Kaspers GL
J Nucl Med; 2017 May; 58(5):711-716. PubMed ID: 27765855
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and pharmacokinetics of [
García-Varela L; Codesido J; Perez-Pedrosa A; Muñoz-González M; Ramos-Docampo E; Rey-Bretal D; García-Otero X; Gómez-Lado N; Turrero A; Beiroa D; Rodríguez-Perez AI; Vidal A; Fernández-Ferreiro A; Pubul V; Aguiar P
Int J Pharm; 2024 Mar; 652():123795. PubMed ID: 38224761
[TBL] [Abstract][Full Text] [Related]
5. Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex.
Chu C; Jablonska A; Lesniak WG; Thomas AM; Lan X; Linville RM; Li S; Searson PC; Liu G; Pearl M; Pomper MG; Janowski M; Magnus T; Walczak P
J Control Release; 2020 Jan; 317():312-321. PubMed ID: 31751635
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
7. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
[TBL] [Abstract][Full Text] [Related]
8. Multiregional Tumor Drug-Uptake Imaging by PET and Microvascular Morphology in End-Stage Diffuse Intrinsic Pontine Glioma.
Veldhuijzen van Zanten SEM; Sewing ACP; van Lingen A; Hoekstra OS; Wesseling P; Meel MH; van Vuurden DG; Kaspers GJL; Hulleman E; Bugiani M
J Nucl Med; 2018 Apr; 59(4):612-615. PubMed ID: 28818988
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies and absorbed dose estimation of [
Zolghadri S; Mohammadpour-Ghazi F; Yousefnia H
Appl Radiat Isot; 2024 Aug; 210():111379. PubMed ID: 38815448
[TBL] [Abstract][Full Text] [Related]
10. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
J Neurosurg Pediatr; 2021 Aug; 28(4):371-379. PubMed ID: 34359048
[TBL] [Abstract][Full Text] [Related]
11. 3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development.
Molotkov A; Doubrovin M; Bhatt N; Hsu FC; Beserra A; Chopra R; Mintz A
Drug Deliv; 2020 Dec; 27(1):1686-1694. PubMed ID: 33263448
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models.
Jansen MH; Lagerweij T; Sewing AC; Vugts DJ; van Vuurden DG; Molthoff CF; Caretti V; Veringa SJ; Petersen N; Carcaboso AM; Noske DP; Vandertop WP; Wesseling P; van Dongen GA; Kaspers GJ; Hulleman E
Mol Cancer Ther; 2016 Sep; 15(9):2166-74. PubMed ID: 27325687
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
[TBL] [Abstract][Full Text] [Related]
14. Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.
Neuwelt EA; Minna J; Frenkel E; Barnett PA; McCormick CI
Am J Physiol; 1986 May; 250(5 Pt 2):R875-83. PubMed ID: 3706572
[TBL] [Abstract][Full Text] [Related]
15. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
[TBL] [Abstract][Full Text] [Related]
16. Phase I/IIa PET imaging study with
Joraku A; Hatano K; Kawai K; Kandori S; Kojima T; Fukumitsu N; Isobe T; Mori Y; Sakata M; Hara T; Nasu K; Minami M; Iizumi Y; Nishiyama H
Ann Nucl Med; 2019 Feb; 33(2):119-127. PubMed ID: 30406361
[TBL] [Abstract][Full Text] [Related]
17. Immuno-PET Imaging of
Li D; Cheng S; Zou S; Zhu D; Zhu T; Wang P; Zhu X
Mol Pharm; 2018 Apr; 15(4):1674-1681. PubMed ID: 29502426
[TBL] [Abstract][Full Text] [Related]
18. Influence of Bevacizumab on Blood-Brain Barrier Permeability and
Stegmayr C; Oliveira D; Niemietz N; Willuweit A; Lohmann P; Galldiks N; Shah NJ; Ermert J; Langen KJ
J Nucl Med; 2017 May; 58(5):700-705. PubMed ID: 28153956
[TBL] [Abstract][Full Text] [Related]
19. Refining the delivery and therapeutic efficacy of cetuximab using focused ultrasound in a mouse model of glioblastoma: An
Porret E; Kereselidze D; Dauba A; Schweitzer-Chaput A; Jegot B; Selingue E; Tournier N; Larrat B; Novell A; Truillet C
Eur J Pharm Biopharm; 2023 Jan; 182():141-151. PubMed ID: 36529256
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
